Millennium Management
RPRX icon

Millennium Management’s Royalty Pharma RPRX Stock Holding History

Millennium Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-116,839
Closed -$4.51M – 6289
2025
Q4 		$4.51M Sell
116,839
-2,118,294
-95% -$80.8M ﹤0.01% 3129
2025
Q3 		$78.9M Buy
2,235,133
+1,768,702
+379% +$64M 0.03% 561
2025
Q2 		$16.8M Buy
466,431
+157,261
+51% +$5.21M 0.01% 1755
2025
Q1 		$9.62M Sell
309,170
-2,106,111
-87% -$66.8M 0.01% 2236
2024
Q4 		$61.6M Sell
2,415,281
-1,926,224
-44% -$51.1M 0.03% 668
2024
Q3 		$123M Buy
4,341,505
+1,991,225
+85% +$55.2M 0.06% 325
2024
Q2 		$62M Sell
2,350,280
-2,316,866
-50% -$64.2M 0.03% 669
2024
Q1 		$142M Buy
4,667,146
+3,052,745
+189% +$90M 0.06% 307
2023
Q4 		$45.3M Sell
1,614,401
-28,433
-2% -$781K 0.02% 865
2023
Q3 		$44.6M Sell
1,642,834
-232,393
-12% -$6.9M 0.02% 781
2023
Q2 		$57.6M Sell
1,875,227
-163,655
-8% -$5.54M 0.03% 642
2023
Q1 		$73.5M Buy
2,038,882
+1,054,516
+107% +$39.1M 0.04% 472
2022
Q4 		$38.9M Buy
984,366
+923,481
+1,517% +$38.5M 0.02% 919
2022
Q3 		$2.45M Sell
60,885
-188,321
-76% -$8.04M ﹤0.01% 3562
2022
Q2 		$10.5M Buy
249,206
+110,837
+80% +$4.54M 0.01% 1972
2022
Q1 		$5.39M Buy
138,369
+105,599
+322% +$4.15M ﹤0.01% 2848
2021
Q4 		$1.31M Sell
32,770
-688,414
-95% -$26.7M ﹤0.01% 4154
2021
Q3 		$26.1M Sell
721,184
-38,016
-5% -$1.48M 0.02% 1090
2021
Q2 		$31.1M Buy
759,200
+599,181
+374% +$25.5M 0.02% 873
2021
Q1 		$6.98M Buy
+160,019
New +$7.59M 0.01% 2197
2020
Q4 		– Sell
-43,557
Closed -$1.83K – 5529
2020
Q3 		$1.83K Sell
43,557
-678,245
-94% -$29.1M ﹤0.01% 2666
2020
Q2 		$35M Buy
+721,802
New +$35.7M 0.05% 453

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management's RPRX Position: Q1 2026 in Review

Millennium Management sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 116,839 shares — an estimated $4.51M sold.

Millennium Management first reported a position in RPRX in Q2 2020 and held it in 22 quarters. The position peaked at $142M in Q1 2024. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Millennium Management reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 116,839 Royalty Pharma shares in Q1 2026, an estimated $4.51M.
  • Millennium Management first reported a position in Royalty Pharma in Q2 2020 and held it in 22 quarters.
  • Millennium Management's Royalty Pharma position peaked at $142M in Q1 2024.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.